Relevant bibliographies by topics / Gemfibrozilo

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Gemfibrozilo'

Author: Grafiati
Published: 4 June 2021
Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Gemfibrozilo.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Gemfibrozilo"

1

Maguiña, Elbis, Fernando Nuevo V., and Jesús Rumiche B. "Análisis costo-efectividad del uso de estatinas frente a gemfibrozilo en pacientes de consultorios externos del Centro Médico Naval: "Cirujano Mayor Santiago Tavara"." Ciencia e Investigación 9, no. 1 (2006): 33–40. http://dx.doi.org/10.15381/ci.v9i1.5090.

Full text
Abstract:
El objetivo de la investigación fue determinar y comparar el costo-efectividad de Atorvastatina 20 mG y Pravastatina 20m mG trente a Gemfibrozilo 600mG, en el tratamiento de hiperlipidemia, e identificar los factores de riesgo. Fue un estudio transversal, descriptivo y retrospectivo, realizado en el Centro Médico Naval, en el período de enero de 2002 a julio de 2005. Se revisaron historias clínicas de 64 pacientes hiperlipidémicos, entre 40 y 64 años, que acuden a los consultorios externos de Cardiología, Endocrinología, Geriatría y Medicina Interna a quienes se les prescribió: Estatinas 20 mg
APA, Harvard, Vancouver, ISO, and other styles
2

García Llopis, Paula, Alejandra González D’huicque, and Vicente Palop Larrea. "Edema facial por gemfibrozilo." Medicina Clínica 135, no. 8 (2010): 384. http://dx.doi.org/10.1016/j.medcli.2009.06.040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Acuña Elvira, Nerea. "Consulta farmacéutica: intoxicación por gemfibrozilo." Farmacéuticos Comunitarios 9, no. 2 (2017): 49–51. http://dx.doi.org/10.5672/fc.2173-9218.(2017/vol9).002.06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tormo Molina, J., I. Gázquez Pérez, and A. Matas Hoces. "Cerivastatina y gemfibrozilo: una combinación peligrosa*." Atención Primaria 28, no. 6 (2001): 438–39. http://dx.doi.org/10.1016/s0212-6567(01)70410-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

de Arriba Méndez, José-Javier, Elena Gómez Merino, José Antonio Sáez Barcelona, and Lourdes Sáez Méndez. "Rabdomiólisis grave asociada a cerivastatina y gemfibrozilo." Medicina Clínica 117, no. 7 (2001): 278–79. http://dx.doi.org/10.1016/s0025-7753(01)72086-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bosch Rovira, T., J. A. Llompart Pou, and J. Forteza-Rey. "Rabdomiólisis asociada al tratamiento combinado con cerivastatina y gemfibrozilo." Revista Clínica Española 201, no. 12 (2001): 731–32. http://dx.doi.org/10.1016/s0014-2565(01)70966-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vascónez Espinosa, F., N. Gómez Rodríguez, A. Martín Joven, and F. J. Posada García. "Rabdomiólisis complicada con insuficiencia renal aguda en un paciente tratado con gemfibrozilo y cerivastatina." Revista Clínica Española 201, no. 4 (2001): 228–29. http://dx.doi.org/10.1016/s0014-2565(01)70806-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alean Flórez, Joel, Daniela Márquez Méndez, Saudith María Burgos Núñez, Germán Enamorado-Montes, and José Marrugo Negrete. "Productos farmacéuticos y de cuidado personal presentes en aguas superficiales, de consumo humano y residuales en el departamento de Córdoba, Colombia." Revista de Investigación Agraria y Ambiental 12, no. 2 (2021): 179–97. http://dx.doi.org/10.22490/21456453.4231.

Full text
Abstract:
Contextualización: gracias al avance de técnicas analíticas sensibles desarrolladas en las últimas décadas, se ha podido identificar y cuantificar la presencia de diversos contaminantes en el medio acuático, dentro de este grupo se encuentran los contaminantes emergentes (CE) conformados por productos de cuidado e higiene personal, antibióticos, hormonas, plastificantes, fármacos y otros que son vertidos a las fuentes de agua alterando el equilibrio de estos ecosistemas. 
 
 Vacío de investigación: diversas investigaciones muestran que los contaminantes emergentes pueden comprometer
APA, Harvard, Vancouver, ISO, and other styles
9

Jiménez-Bambague, Eliana M., Carlos A. Madera-Parra, and Enrique J. Peña-Salamanca. "Eliminación de compuestos farmacéuticos presentes en el agua residual doméstica mediante un tratamiento primario avanzado." INGENIERÍA Y COMPETITIVIDAD 22, no. 1 (2020): 10. http://dx.doi.org/10.25100/iyc.v22i1.8794.

Full text
Abstract:
Se evaluó la presencia de compuestos farmacéuticos de los grupos terapéuticos antiepilépticos, agentes hipolipemiantes, analgésicos antiinflamatorios y tranquilizantes en tres jornadas de muestreo, además se estimó la eficiencia de eliminación mediante un tratamiento primario avanzado (TPA) con procesos de coagulación, floculación y sedimentación en la planta de tratamiento de agua residual de la ciudad de Cali (Colombia). De los compuestos medidos, 10 estuvieron por encima del límite de detección de la técnica analítica usada: carbamazepina, 10,11-Dihidro-10,11-dihidroxicarbamazepina, gabapen
APA, Harvard, Vancouver, ISO, and other styles
10

Martín-Navarro, Juan Antonio, Vladimir Petkov-Stoyanov, María José Gutiérrez-Sánchez, and Luis Pedraza-Cezón. "Fracaso renal agudo por nefritis intersticial aguda con síndrome de Fanconi en relación con metamizol y gemfibrozilo." Nefrología 36, no. 3 (2016): 321–23. http://dx.doi.org/10.1016/j.nefro.2015.06.022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Gemfibrozilo"

1

Breña, Figueroa Mirtha Rocío. "Diseño y desarrollo de una formulación para Gemfibrozilo 600 mg. tableta recubierta." Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 2005. https://hdl.handle.net/20.500.12672/2603.

Full text
Abstract:
En el presente trabajo se han evaluado tres formulaciones para Gemfibrozilo 600 mg tableta recubierta, una realizada por compresión directa y dos por granulación húmeda, de las cuales se ha seleccionado a la formulación que cumple los parámetros establecidos para el dosaje, disolución y los factores de deferencia (F1) y similitud (F2), estos factores fueron determinados a través de la comparación por perfil de disolución con respecto al producto innovador. Se realizó el estudio de estabilidad acelerada (40ºC ± 2 ºC / 75% de humedad relativa ± 5%.), estabilidad a largo plazo (25 ºC ± 2 ºC / 60
APA, Harvard, Vancouver, ISO, and other styles
2

Maguiña, Cacha Elbis Jhon, and Verástegui Diocelino Fernando Nuevo. "Análisis costo-efectividad del uso de estatinas frente a gemfibrozilo en pacientes de consultorios externos del Centro Médico Naval : Cirujano Mayor Santiago Távara." Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 2006. https://hdl.handle.net/20.500.12672/2326.

Full text
Abstract:
El presente es un estudio transversal, descriptivo y retrospectivo realizado en el Centro Médico Naval “Santiago Távara”, ubicado en Av. Venezuela s/n Bellavista-Callao, con el objetivo de determinar y comparar el costo-efectividad de Estatinas (Atorvastatina 20mg y Pravastatina 20 mg) frente a Gemfibrozilo 600 mg en el tratamiento de hiperlipidemia durante el período de enero 2002 a julio 2005. Se revisaron las historias clínicas de 64 pacientes hiperlipidémicos, con edades entre los 40 y 64 años de ambos sexos que acuden a los consultorios externos de Cardiología, Endocrinología, Geriatría y
APA, Harvard, Vancouver, ISO, and other styles
3

Hemingway, Cheryl Joy. "Investigation of the molecular mechanisms of inhibition of hepatic fatty acid and cholestral biosynthesis by hypolipidaemic agents." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285489.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chamouret, Sandrine. "Le gemfibrozil : étiologie possible de pneumopathies médicamenteuses : à propos de deux cas." Saint-Etienne, 1995. http://www.theses.fr/1995STET6222.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Prindiville, John S. "Circulating lipoproteins and tissue lipids: Effects of gemfibrozil on lipid metabolism in rainbow trout." Thesis, University of Ottawa (Canada), 2010. http://hdl.handle.net/10393/28555.

Full text
Abstract:
Lipids support crucial functions in teleost fish, including the production of energy; lipoproteins support the movement of lipids through the vascular system. The objective of this thesis was to determine if gemfibrozil (GEM), a mammalian PPARalpha agonist pharmaceutical, could alter the circulating lipoproteins and tissue lipid metabolism in the rainbow trout, Oncorhynchus mykiss. Injections of GEM lowered the concentration of lipoproteins and changed their size distribution, lipid and fatty acid content. These changes were associated with an increased lipoprotein lipase transcript level but
APA, Harvard, Vancouver, ISO, and other styles
6

Santos, Tiago André Azevedo dos. "Fish personality, memory and learning hability: the effect of pharmaceuticals and abiotic factors." Master's thesis, Universidade de Aveiro, 2017. http://hdl.handle.net/10773/22023.

Full text
Abstract:
Mestrado em Biologia Molecular e Celular<br>Over the last years, animal personality has been gaining a lot of attention from the scientific community, and, at the moment, it is being questioned its importance in survival and the evolution of species in stress situation. Between all of potential stress agents, there are emerging environmental contaminants, such as, pharmaceuticals. However, there are not many behavior and personality studies in fish. The present work aims to increase the knowledge of how factors associated with personality can influence the response to pharmaceuticals detected
APA, Harvard, Vancouver, ISO, and other styles
7

Filho, José Joaquim Fernandes Raposo. "Suco de laranja tem efeito sinérgico à estatina e ao genfibrozila no tratamento da aterosclerose." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-22092010-162733/.

Full text
Abstract:
FUNDAMENTO: O suco de laranja (Citrus sinensis) é rico em vitami-na C, folatos e seu principal flavonóide, a hesperidina, cuja conformação es-pacial é semelhante à genisteína de soja que tem ação favorável sobre o aparelho cardiovascular. A vitamina C é conhecida como potente inibidor da peroxidação lipídica. Mas sua capacidade por possuir efeitos terapêuticos no tratamento da aterosclerose é pouco estudada. OBJETIVO: O presente tra-balho visa a determinar se o suco de laranja pode ter efeito aditivo no trata-mento com estatinas e fibratos, reduzindo placas ateroscleróticas e a quanti-dade de
APA, Harvard, Vancouver, ISO, and other styles
8

Laser, Eric [Verfasser], Olaf [Gutachter] Picker, and Georg [Gutachter] Flügen. "Der Einfluss von Gemfibrozil und Pravastatin auf die mitochondriale Funktion im Colon und in der Leber in vitro - Ein Therapieansatz bei Sepsis? / Eric Laser ; Gutachter: Olaf Picker, Georg Flügen." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2021. http://d-nb.info/1230135111/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bergman, Ebba. "The Hepatobiliary Transport of Rosuvastatin In Vivo." Doctoral thesis, Uppsala universitet, Institutionen för farmaci, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-109866.

Full text
Abstract:
In vivo studies of hepatobiliary disposition are challenging. The hepatobiliary system is complex, as its physiological localization, complex cellular structure with numerous transporters and enzymes, and the interindividual variability in protein expression and biliary flow will all affect the in vivo disposition of a drug under investigation. The research included in this thesis has focused on the involvement of hepatic transport proteins in the hepatobiliary disposition of rosuvastatin. The impact that several transport inhibitors had on the pharmacokinetics of rosuvastatin was investigated
APA, Harvard, Vancouver, ISO, and other styles
10

Dah-Chung, Owe Yang, and 歐陽大中. "The Synthesis of Gemfibrozil." Thesis, 1994. http://ndltd.ncl.edu.tw/handle/75834394951751380638.

Full text
Abstract:
碩士<br>國立成功大學<br>化學工程研究所<br>82<br>2,2-dimethyl-5(2,5-xylyloxy) valeric acid, known as gemfibrozil, and used for treatment or prevention of arteriosclerosis, can be produced by these ways: (1) Abstraction of proton from Me2CHCOPh using NaNH2 followed by alkylation with Br(CH2)3Cl resulted in Cl(CH2)3CMe2COPh(b). Refluxing b with anhydrous K2CO3,KI and 2,5-xylenol in a medium polar solvent gave 2,5-Me2C6H3O(CH2)3CMe2COPh. The latter was heated with KOCMe3 in anisole to yield gemfibrozil. The r
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Gemfibrozilo"

1

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wood, Clive. Further Progress With Gemfibrozil. Royal Society of Medicine, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Publications, ICON Health. Gemfibrozil - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Gemfibrozilo"

1

Ciuffetti, G., G. Orecchini, D. Siepi, G. Lupattelli, and A. Ventura. "Hemorheological Activity of Gemfibrozil in Primary Hyperlipidemias." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_69.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Giudici, G. A., F. Pagani, C. Selvini, P. Stefanoni, C. Di Santo, and C. Vergani. "Effects of Gemfibrozil on Lipoproteins in Patients with Dyslipoproteinemia." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Steiner, G. "Relationship of glucose intolerance and elevated triglyceride: implications for gemfibrozil." In Atherosclerosis and Cardiovascular Diseases. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yoshida, Hiroshi, Makoto Ayaori, Tetsuya Hisada, Toshitsugu Ishikawa, Fumitaka Ohsuzu, and Haruo Nakamura. "Beneficial Effect of Gemfibrozil on LDL Chemicophysical Characteristics and Oxidizability." In Lipoprotein Metabolism and Atherogenesis. Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-68424-4_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Manzato, E., S. Zambon, R. Marin, G. Baggio, and G. Crepaldi. "Plasma Lipids, Lipoproteins, and Apoproteins During Gemfibrozil Treatment in Primary Hyperlipidemias." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_66.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kashyap, M. L., and K. Saku. "HDL Deficiency, Atherosclerosis, and Stimulation of HDL Synthesis: Role of Gemfibrozil." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Barbara, L., G. Mazzella, N. Villanova, et al. "Effect of Gemfibrozil Administration on Biliary Lipid Secretion: A Crossover Study with Clofibrate." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Allhoff, Peter, Ulrich Laaser, and Joachim Heinrich. "Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle Aged Men with Dyslipidemia." In Kompendium der Lipid-Studien. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-95642-3_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kashyap, Moti L., and Keijiro Saku. "HDL Metabolism in HDL Deficiency Associated with Familial Hypertriglyeridemia: Effect of Treatment with Gemfibrozil." In Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia, in Vivo Kinetics. Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5904-3_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

van Tol, Arie, Juhani Kahri, Bernhard Eisele, Timo Sane, and Marja-Riitta Taskinen. "Gemfibrozil Increases Plasma Levels of Cholesterylester Transfer Protein (Cetp), But Lowers Cholesterylester Transfer in Hypertriglyceridemic Subjects." In Drugs Affecting Lipid Metabolism. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0311-1_65.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Gemfibrozilo"

1

Benitta, T. Asenath, G. K. Balendiran, C. James, V. K. Vaidyan, and V. S. Jayakumar. "Vibrational Spectral Studies of Gemfibrozil." In PERSPECTIVES IN VIBRATIONAL SPECTROSCOPY: Proceedings of the 2nd International Conference on Perspectives in Vibrational Spectroscopy (ICOPVS 2008). AIP, 2008. http://dx.doi.org/10.1063/1.3046218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Laustiola, K., R. Lassila, P. Koskinen, and V. Manninen. "GEMFIBROZIL HAS ANTI-PLATELET EFFECTS IN PATIENTS WITH HYPERCHOLESTEROLAEMIA DURING PHYSICAL STRESS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643462.

Full text
Abstract:
Earlier studies indicate an increased platelet reactivity in patients with hypercholesterolaemia. Physical and mental stress have also been reported to cause increased reactivity. The present study was undertaken to evaluate the effect of gemfibrozil (G) a new lipid lowering drug on platelet reactivity during physical stress. Ten otherwise healthy male subjects with serum cholesterol levels above 7 mmol/l were involved in a double-blind study. It consisted of two treatment periods of 8 weeks during which the patients were given either G (600 mg b.i.d.) or placebo (PI) and an 8 weeks wash-out p
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Yanghe, Chenguang Sheng, and George Agbai Nnanna. "Detection of Selected Pharmaceutical Contaminants and Removal Efficiency of Emerging Contaminants by Application of Membrane Filtration Technology." In ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-36906.

Full text
Abstract:
Removal of emerging contaminants is considered to be one of the most important processes within advanced Waste Water Treatment Plants (WWTPs) system. Pharmaceutical contaminants in drinking water could potentially lead to human’s increasing risks of heart attacks, organ damage, mental health and even cancer. This paper investigates the emerging contaminant removal efficiencies of technologies employed by local WWTPs. After determining the presence of selected emerging contaminants (17β-estradiol, Acetaminophen, Carbamazepine, Diclofenac, Erythromycin, Estrone, Bezafibrate, Fluoxetine, Gemfibro
APA, Harvard, Vancouver, ISO, and other styles
4

Sheng, Chenguang, A. G. Agwu Nnanna, Yanghe Liu, and John D. Vargo. "Removal of Pharmaceutical Contaminants in Water." In ASME 2015 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2015. http://dx.doi.org/10.1115/imece2015-53240.

Full text
Abstract:
Pharmaceutical contaminants in drinking water could potentially lead to increasing risks of heart attacks, organ damage, mental health and even cancer. Because their presence, frequency of occurrence, or source may not be known, the chemicals being discovered in water that previously had not been detected or are being detected at levels that may be significantly different than expected. Removal of emerging contaminants is considered recently to be one of the most important processes within advanced Waste Water Treatment Plants (WWTPs) system. EPA is working to improve its understanding of a nu
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Gemfibrozilo' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography